BACKGROUND: Because @entity5030 is implanted unusually low in the uterus, it may cause major, and/or repeated, antepartum @entity548 . The traditional policy of care of @entity1 with symptomatic @entity5030 includes prolonged stay in hospital and delivery by caesarean section. OBJECTIVES: To assess the impact of any clinical intervention applied specifically because of a perceived likelihood that a pregnant @entity1 might have @entity5030 . SEARCH STRATEGY: A comprehensive electronic search was performed to identify relevant literature. Searched databases included the Trials Register maintained by the Cochrane Pregnancy and Childbirth Group (August 2002), and the Cochrane Controlled Trials Register (The Cochrane Library, Issue 2, 2002). SELECTION CRITERIA: Any controlled clinical trial that has assessed the impact of an intervention in @entity1 diagnosed as having, or being likely to have, @entity5030 . DATA COLLECTION AND ANALYSIS: Data were extracted, unblinded, by the author without consideration of results. MAIN RESULTS: Three trials were included, involving a total of 114 @entity1 . Both tested interventions (home versus hospitalisation and cervical cerclage versus no cerclage) were associated with reduced lengths of stay in hospital antenatally: weighted mean difference (WMD) respectively -18.50 days (95% confidence interval (CI) -26.83 to -10.17), -4.80 days (95% CI -6.37 to -3.23). Otherwise, there was little evidence of any clear advantage or disadvantage to a policy of home versus hospital care. The one @entity1 who had a @entity548 severe enough to require immediate transfusion and delivery was in the home care group. Cervical cerclage may reduce the risk of delivery before 34 weeks: relative risk (RR) 0.45 (95% CI 0.23 to 0.87), or the birth of a baby weighing less than two kilograms RR 0.34 (0.14 to 0.83) or having a low five minute Apgar score RR 0.19 (0.04 to 1.00). In general, these possible benefits were more evident in the trial of lower methodological quality. REVIEWER'S CONCLUSIONS: There are insufficient data from trials to recommend any change in clinical practice. Available data should, however, encourage further work to address the safety of more conservative policies of hospitalisation for @entity1 with suspected @entity5030 , and the possible value of insertion of a cervical suture.

Interventions for suspected XXXX .

@entity1 :: ('9606', 'Species') :: ['woman', 'women'] @entity5030 :: ('MESH:D010923', 'Disease') :: ['placenta praevia'] @entity548 :: ('MESH:D006470', 'Disease') :: ['haemorrhage']
@entity5030 :: (MESH:D010923,Disease) :: ['placenta praevia']
